Quest diagnostics granted cdc contract to support covid-19 infection and vaccination seroprevalence research

Quest to employ its comprehensive menu of covid-19 antibody test and data analytics services to support population health research across 45 states and puerto rico secaucus, n.j., march 23, 2022 /prnewswire/ -- quest diagnostics (nyse: dgx), the world's leading provider of diagnostic information services, today announced that it has been granted a contract by the centers for disease control and prevention (cdc) to perform testing and provide laboratory data analysis to help identify patterns in sars-cov-2 seroprevalence on a multistate basis.
DGX Ratings Summary
DGX Quant Ranking